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Abstract 
Background: New studies have been carried out in understanding the 
molecular mechanism of OSCC and identifying the molecular markers useful 
for diagnosing a tumor at an early stage. Diagnosis at an early stage, could be 
associated with the favorable prognosis and a 5-year survival rate of 60-80%. 
Aims of the study: To assess P-cad expression at perilesional area of OSCC 
and correlate such expression to OSCC histopathological grading.  
Materials and methods: Immunohistochemical evaluation of P-cad 
expression at perilesional area of 20 OSCC and 10 normal oral mucosa from 
archival paraffin blocks was done by using mouse monoclonal P-cad 
antibody. The sections were assessed according to the ability of surface 
epithelium at perilesional area of OSCC in showing normal expression 
pattern of P-cad in oral mucosa.  
Results: The present study showed membranous basal and parabasal 
expression in all cases of normal oral mucosa while perilesional areas of 
OSCC revealed  high multiple layers expression of P-cad in (45%) , this  
anomalous expression  support the genetic alteration in  perilesional area and 
gave a clue for a common cell clone for both tumor and the adjacent 
perilesional area. There were multiple layers staining of P-cad in (46.6%) of 
WDSCC, however, statistical analysis did not reach any significant level in 
relation to histopathological grading. 
Conclusion: Increase P-cad expression at the perilesional area has an 
important initial role in early step of carcinogenesis, and the aberrant 
expression of P-cad at the perilesional area might have a role in the mode of 
the invasion and prognosis of oral cancer.  
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Introduction: Oral squamous cell carcinoma (OSCC) represents the 
sixth most diffused cancer in developed countries. In spite of new treatment 
modalities. The mortality rate remained high (~50%). New studies have been 
carried out in understanding the molecular mechanism of OSCC,  and 
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identifying the molecular markers useful for diagnosing a tumor at an early 
stage. Diagnosis at an early stage, could be associated with the favorable 
prognosis and a 5-year survival rate of 60-80% (Aguzzi  et al, 2009  ). 
The tried clinical examination and heightened awareness remain the 
mainstay of early OSCC detection, however, technology available might 
help the development of useful techniques and devices for the detection of 
potentially pre-malignant and early malignant conditions (Kujan  et al 
,2009).  
Clinical staging (TNM) have an important influence on the survival 
and prognosis of OSCCs patients. Unfortunately, approximately 60% to 65% 
of diagnosed patients are in late stage (stages III and IV). This delay could be 
related to either patient or professional cause (Gao and Guo , 2009; Akbulut  
et al , 2011). 
The sequential genetic changes that drive a cell towards malignancy 
occur over several years. In view of this, the American Association for 
Cancer Research recognized the importance of targeting and treatment of 
early cancerous lesions to prevent or regress carcinogenesis (O'Shaughnessy 
et al, 2002). Significant efforts of identification of the biomarkers in normal 
tissues adjacent to tumors (peri-tumoral cancer fields), might be useful for 
primary chemoprevention studies (Tsao et al, 2004). 
Individuals with one carcinoma of the head and neck region have an 
increased risk of developing a second malignancy; the frequency of that 
event varies from 16% to 36%. When a second malignancy occurs at the 
same time as the initial lesion, it is called a synchronous carcinoma 
(Schwartz et al, 1994). "Lateral cancerization" was subsequently used to 
indicate the lateral spread of tumors which was due to progressive 
transformation of cells adjacent to a tumor, rather than the spread and 
destruction of the adjacent epithelium by pre-existing cancer cells (Dakubo 
et al, 2007). It was observed that normal looking cells in close proximity to 
malignant cells were histologically abnormal and therefore were considered 
as a part of the transformed cells in a particular tumor field, and 
consequently were responsible for the occurrence of local tumor recurrences 
(Braakhuis et al, 2003). Second primary tumors are the chief cause of death 
in patients with an early stage diagnosis (Hong et al, 1990). The tendency to 
develop multiple carcinomas in the upper aerodigestive region is known as 
"field cancerization." (Dakubo et al ,2007; Slaughter et al ,1953 ) .  
Prolonged and diffuse exposure to local carcinogens, particularly tobacco 
combined with alcohol, appears to increase the malignant transformation 
potential of exposed epithelial cells (Fortuna and  Mignogna, 2011). 
P-cad is cell adhesion molecule, which is only expressed in the basal 
and suprabasal cell layers of the normal oral epithelium. During tumor 
progression, P-cad expression increases in the initial stage of tumor growth , 
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whereas a reduced membranous and or an enhanced cytoplasmic expression 
of P-cad is observed at the invasion front of oral squamous cell carcinoma 
(OSCC) (Bauer et al , 2013 ). 
Furthermore, studies revealed that the expression of an inappropriate 
cadherin in epithelial cells is yet another way that tumor cells can alter their 
adhesive function (Pyo et al,2007 ). 
Understanding molecular mechanisms regulating oral carcinoma 
progression is a prerequisite for improving the patient prognosis. At the first 
step of progression,  epithelial cells must sequester from their primary sites 
and invade into the basement membrane and underlying tissues. This step 
requires the dissociation of cell-cell adhesion.  , later on invasion  in a form 
of small subsets or individuals of cells, that  predispose them to a more 
advanced state of progression (Hashimoto et al , 2012 ). 
Aims of the study: To evaluate the P-cad expression and distribution 
whether single basal and multiple layers and its cellular localization 
(membranous or cytoplasmic  and mix ) in the oral epithelia at  perilesional 
area  of  OSCC  lesions and relate such expression to OSCC 
histopathological grading.  
 
Materials and Methods 
A total of 20 archival paraffin blocks previously diagnosed as OSCC 
with perilesional  area  were collected from  Baghdad and Sulaimani 
histopathological centers. Ten blocks of mucoceal covered by normal oral 
mucosa were obtained from Oral Pathology Department at Sulaimani 
University and used as positive controls. The study was approved by both the 
scientific and ethical committee in the college. 
Serial 4µm sections were cut, one section was stained with 
hematoxylin and eosin to identify the perilesional area of the lesion and 
histopathological grading of OSCC , the other section  was mounted on 
positively charged slide and  stained  immunohistochemistry with P-cad . 
Sections were deparaffinized and rehydrated, then retrieved by antigen 
retrieval solutions (Citrate buffer, pH 6) by using the pressure cooker (for 15 
min). Endogenous peroxidase activity was blocked by incubating the 
sections with 1% H2O2 in PBS (for 10 min).  In order to prevent non –
specific binding sections were incubated with 1.5% blocking serum (for 1 
hour) . Then sections were incubated with the primary mouse monoclonal 
antibody of P-cad (U.S Biological; diluted at 1:20) for three quarters of an 
hour at 37°C in a humid chamber. Biotinylated secondary antibody was 
applied for 30 min at 37°C,  then detection was performed by using avidin-
biotin peroxidase technique for 30 min at 37°C  . The reaction was visualized 
by incubation  with diaminobendizine for 10 min, then sections were counter 
European Scientific Journal   December 2013  edition vol.9, No.36  ISSN: 1857 – 7881 (Print)  e - ISSN 1857- 7431 
  
437 
 
stained with hematoxylin. Negative control slides were obtained by omitting 
the primary antibody. 
Slides were assessed blindly by the author. The sections were 
evaluated   according to the ability of surface epithelium in perilesional area 
adjacent to OSCC  in showing normal pattern of  membranous staining in 
basal and parabasal layer (Lo Muzio  et al 2004 ; Lo Muzio  et al 2005; 
Bauer et al, 2008) and the location  of P-cad expression was determined   ( 
whether basal, multiple layers ) and accordingly the  surface epithelia in  
perilesional  area , was  evaluated by using   the following score ( Pyo et al 
2007 ): 
1. A increases expression: sections showed staining over suprabasal layer.  
2. Unchanged expression, sections revealed immunoreactivity that was 
confined to limited layer of basal cells. 
3. Decreased expression, sections showed faint staining. 
SPSS statistical software was used to estimate Chi-square and 
Pearson's correlation coefficient. Probabilities of less than 0.05 were 
accepted as significant.  
 
Results and Discussion 
Several studies demonstrated the altered expression of P-cad and E-
cad in OSCC. This work for the first time evaluate P-cad expression at 
perilesional area of OSCC. 
Understanding of the molecular alteration of perilesional area could 
not only assist the diagnosis and prognosis of oral cancer but might also open 
up novel therapeutic approaches (Díez-Pérez et al, 2011). 
Interestingly, authors detected 72.73% methylation of p16 in healthy 
peritumoral tissue, suggesting that methylation of this marker might be an 
early event in carcinogenesis and could  therefore serve as a prognostic and 
diagnostic marker (Kato et al,2006 ). On the other hand, a higher level (up to 
4-fold) of methylation was found in histologically healthy samples from 
patients previously treated for OSCC, indicating a greater predisposition to 
tumor recurrence (Ruesga et al, 2007).  Furthermore, it was reported that E-
cad methylation was found in 33.3% of the perilesional area, with 12.5% of 
these showing the same degree of methylation as the cancerous lesion.  
(Díez-Pérez   et al, 2011; Yeh et al, 2002). 
This study showed normal basal and parabasal expression in all cases 
of normal oral mucosa Fig 1-A.  All the perilesional cases were positive for 
P-cad. Multiple layers expression of P-cad was found in 45% of perilesional  
area of OSCC , as shown in Table 1, Fig 1-B.  Pyo et al, 2007 found 53% of 
P- cad multiple layer expression in the OSCC islands, this evidence support 
molecular findings shown that a tumor could be surrounded by a mucosal 
field of genetically altered cells. Furthermore, these cells could share some 
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or even all genetic markers with the tumor, indicating that both have arisen 
from a common cell clone (Braakhuis  et al, 2002). In addition this over 
expression of P-cad at perilesional area of oral cancer might give an idea that 
this marker could play an important role in early stage of carcinogenesis.  
7/15 (46.6%) of WDSCC showed multiple layer expression Table 2, 
Fig1-B.  This anomalous or over expression of P-cad in perilesional area 
could be a biological marker for the initial phase of tumor growth (Lo Muzio  
et al, 2005).  On the other hand, 5/15, 33.3% of WDSCC revealed faint 
cytoplasmic staining Table -2, Fig 1-C, this finding could be attributed to the 
size of perilesional area as  4/5 of these cases revealed small perilesional 
area. Furthermore 3/15, 20% of WDSCC demonstrated anomalous 
expression of P-cad that was limited to basal layer (cytoplasmic or mixed 
membranous and cytoplasmic) Table 2, Fig 1-D. As the loss of P-cad 
expression probably comes after cytoplasmic relocalization and considered 
as a late event prior to invasion (Williams et al, 1998). Thus this expression 
might have a role in the mode and path of invasion (whether the cancer cells 
invasion occur in sheets or strands or single separating cells) and later on 
prognosis of OSCC.   
Finally the single PDSCC case showed membranous expression of P-
cad in its perilesional area that is limited to basal layer, Table 2, Fig1-E , 
although this expression normally  detected  in normal oral mucosa , this 
result probably  might be due partially to  its small perilesional area and the 
limitation  in the collected sample in the present study in general. However, 
statistical findings did not show any significant difference with 
histopathological grading as p >0.05. 
 
Conclusion 
The over expression of P-cad in perilesional area of OSCC declare 
the important role of this marker in early step of carcinogenesis and support 
the field of cancerization.  Furthermore, the anomalous or over expression of 
this marker could have a role in subsequent method of invasion and 
prognosis of OSCC.  
 
References: 
Aguzzi A ,  Maggioni D , Nicolini G,  Tredici G,  Gaini M R and  Garavello 
W . MAP Kinase Modulation in Squamous Cell Carcinoma of the Oral 
Cavity. Antican Res 2009, 29: 303-308. 
Kujan O, Glenny A-M, Oliver R, Thakker N, Sloan P. Screening 
programmes for the early detection and prevention of oral cancer. Aust Dent 
J 2009, 54: 170–172. 
Gao W, Guo CB. Factors related to delay in diagnosis of oral squamous cell 
carcinoma. J Oral Maxillofac Surg 2009, 67:1015-1020. 
European Scientific Journal   December 2013  edition vol.9, No.36  ISSN: 1857 – 7881 (Print)  e - ISSN 1857- 7431 
  
439 
 
Akbulut N, Oztas B, Kursun S and Evirgen S. Delayed diagnosis of oral 
squamous cell carcinoma: a case series . J Med Case Rep 2011, 5:291. 
O'Shaughnessy JA, Kelloff GJ, Gordon GB, Dannenberg AJ, Hong WK, 
Fabian CJ, Sigman CC, Bertagnolli MM, Stratton SP, Lam S, Nelson WG, 
Meyskens FL, Alberts DS, Follen M, Rustgi AK, Papadimitrakopoulou V, 
Scardino PT, Gazdar AF, Wattenberg LW, Sporn MB, Sakr WA, Lippman 
SM, Von Hoff DD. Treatment and prevention of intraepithelial neoplasia: an 
important target for accelerated new agent development. Clin Cancer Res 
2002;8:314–346. 
Tsao AS, Kim ES, Hong WK. Chemoprevention of cancer. CA Cancer J Clin 
2004; 54:150–180 
Schwartz LH, Ozsahin M, Zhang GN, et al. Synchronous and metachronous 
head and neck carcinomas. Cancer 1994; 74:1933-8. 
Dakubo DG,  Jakupciak  PJ,  Birch-Machin AM, and  Parr LR.  Clinical 
implications and utility of field cancerization. Cancer Cell Int 2007; 7: 2.  
Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH. A 
genetic explanation of Slaughter's concept of field cancerization: evidence 
and clinical implications. Cancer Res 2003; 63:1727–1730. 
Hong WK, Lippman SM, Itri LM, et al. Prevention of secondary primary 
tumors with isotretinoin in squamous cell carcinoma of the head and neck. N 
Engl J Med 1990; 323:795-801, 8257. 
Slaughter DP, Southwick HW, Smejjkal W. "Field cancerization" in oral 
stratified squamous epithelium. Cancer 1953; 6:963-8. 
Fortuna G,  Mignogna  DM. Oral field cancerization. CMAJ  2011 ,183  
:110172 
Bauer K, Gosau M, Reinders J,  Oefner P,  Reichert ET and  Bauer R. 
Presenilin 1/γ-secretase modulates P-cadherin processing and influences cell 
adhesion in oral squamous cell carcinoma cell lines. Carcinogenesis 2013 , 
10: 1093. 
Pyo SW,Hashimoto M,Kim YS, Kim  CH, Lee SH, Johnson KR, Wheelock 
M J and Park JU. Expression of E-cadherin, P-cadherin and N-cadherin in 
oral squamous cell carcinoma: correlation with the clinicopathologic features 
and patient outcome. J Craniomaxillofac Surg 2007; 35:1-9.  
Hashimoto T, Soeno Y, Maeda G, Taya Y,  Aoba T, Nasu M, Kawashiri S,  
Imai K.  progression of oral squamous cell carcinoma accompanied with 
reduced E-cadherin expression but not cadherin switch. PLoS ONE 2012, 
7(10): e47899.  
Lo Muzio L, Pannone G, Mignogna MD, Staibano S, Mariggiò MA, Rubini 
C, Procaccini M, Dolci M, Bufo P, De Rosa G and Piattelli A. P-cadherin 
expression predicts clinical outcome in oral squamous cell carcinomas. 
Histol Histopathol 2004; 19:1089-99. 
European Scientific Journal   December 2013  edition vol.9, No.36  ISSN: 1857 – 7881 (Print)  e - ISSN 1857- 7431 
  
440 
 
Lo Muzio L, Campisi G, Farina A, Rubini C, Pannone G, Serpico 
R,.LainoG, De Lillo A and Carinci F. P-cadherin expression and survival 
rate in oral squamous cell carcinoma: an immunohistochemical study. BMC 
Cancer 2005; 5:63. 
Bauer  R ,Dowejko D, Driemel O, Boßerhoff  AK and Reichert TE 
.Truncated P-cadherin is produced in oral squamous cell carcinoma .FEBS J 
2008; 275: 4198–4210. 
Díez-Pérez  R, Campo-Trapero J , Cano-Sánchez J.,  López-Durán M,. 
Gonzalez-Moles M.A,. Bascones-Ilundain J and Bascones-Martinez A. 
Methylation in oral cancer and pre-cancerous lesions (Review).  Oncol Rep 
2011, 25: 1203-1209, 2011. 
Kato K, Hara A, Kuno T, et al: Aberrant promoter hypermethylation of p16 
and MGMT genes in oral squamous cell carcinoma and the surrounding 
normal mucosa. J Cancer Res Clin Oncol 2006, 132: 735-743,  
Ruesga MT, Acha-Sagredo A, Rodríguez MJ, et al: p16INK4a promoter 
hypermethylation in oral scrapings of oral squamous cell carcinoma risk 
patients. Cancer Lett 2007, 250: 140-145. 
Yeh KT, Shih MC, Lin TH, et al: The correlation between CpGmethylation 
on promoter and protein expression of E-cadherin in oral squamous cell 
carcinoma. Anticancer Res 2002, 22: 3971-3976,. 
Braakhuis  JMB, Tabor  PM, Leemans RC, der Waal I, Snow BG,  
Brakenhoff  HR . Second primary tumors and field cancerization in oral and 
oropharyngeal cancer: Molecular techniques provide new insights and 
definitions. Head & Neck 2002,24 :198–206. 
Williams H.K, Sanders D.S A, Jankowski JA Z, Landini G. and Brown A.M 
S. Expression of cadherins and catenins in oral epithelial dysplasia and 
squamous cell carcinoma. J. Oral Pathol 1998; 27:308-317. 
 
 
Table -1:  P-cad expression in perilesional area of OSCC 
Positive 
cases  20 
Staining limited to 
basal layer 
Multiple layers staining Faint  cytoplasmic 
staining 
No % No % No % 
4 20 9 45 7 35 
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Table- 2:  P-cad expression and localization in relation to histopathological grading at the 
perilesional area of OSCC* 
No significant difference was found as P >0.05 
 
A- B- 
 
C- D- 
Histo-
patholog
ical 
grading 
of 
OSCC 
 
Staining limited to the basal layer  (4) 
 
Multiple layers staining 
(9) 
 
Faint cytoplasmic 
staining     (7) 
 Memb Cyto Mix Memb Cyto Mix Basal Basal and 
parabasal 
Positive 
cases No % No % No % No % No % No % No % No % 
Well   
15   1 6.6 2 
13.
3 1 6.6   6 
4
0 3 
2
0 2 
13.
3 
Moderat
e 4           2 
5
0 2 
5
0   
Poor  1 1 100               
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E- 
 
 
. 
Figure1- P-cad expression in  normal oral mucosa and perilesional areas of  OSCCC X40 
A- Positive expression of P-cad in normal oral mucosa shows membranous basal and 
parabasal expression B- WDSCC with membranous expression of multiple layers C – 
WDSCC with faint  cytoplasmic expression    D-WDSCC with membranous and 
cytoplasmic expression  limited to basal layer X40  E-. PDSCC with membranous 
expression limited to basal layer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
